Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDCC Regulatory News (DCC)

Share Price Information for DCC (DCC)

Share Price is delayed by 15 minutes
Get Live Data
6,000.00    -25.00 (-0.41%)
Bid:
5,995.00
Ask:
6,000.00
Spread: 5.00 (0.083%)
Market Cap: £5.13b
DCC Live PriceLast checked at - London Stock Exchange

Intraday DCC Share Chart

Form 38.5b-DCC PLC

26 May 2026 07:00

RNS Number : 5535F
Goldman Sachs & Co. LLC
25 May 2026
 

 

FORM 38.5(b)

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNISED INTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

 

1. KEY INFORMATION

 

Name of exempt principal trader

GOLDMAN SACHS & CO. LLC

Company dealt in

DCC PLC

Class of relevant security to which the dealings being disclosed relate (Note1)

EUR 0.25 ordinary shares

Date of dealing

22 May 2026

 

2. INTERESTS AND SHORT POSITIONS

 

(a) Interests and short positions (following dealing) in the class of relevant security dealt in  (Note 2)

 

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

74,783

(0.09)

74,773

(0.09)

(2) Derivatives (other than options)

0

(0.00)

189

(0.00)

(3) Options and agreements to purchase/sell

0

(0.00)

0

(0.00)

Total

74,783

(0.09)

74,962

(0.09)

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in  (Note 2)

 

Class of relevant security:

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

 

3. DEALINGS (Note 3)

(a) Purchases and sales

 

Purchase/sale

Number of relevant securities

Price per unit  (Note 4)

Sale (Borrow Partial Return)

4,419

N/A

 

(b) Derivatives transactions (other than options transactions)

 

Product name, e.g. CFD

Nature of transaction  (Note 5)

Number of relevant securities  (Note 6)

Price per unit  (Note 4)

 

(c) Options transactions in respect of existing relevant securities

 

(i) Writing, selling, purchasing or varying

 

Product name,e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates  (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit  (Note 4)

 

(ii) Exercising

 

Product name,e.g. call option

Number of securities

Exercise price per unit  (Note 4)

 

(d) Other dealings (including transactions in respect of new securities)  (Note 3)

 

Nature of transaction  (Note 7)

Details

Price per unit (if applicable)  (Note 4)

 

4. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. 

NONE

 

Is a Supplemental Form 8 attached? (Note 9) YES

 

Date of disclosure

25 May 2026

Contact name

Papa Lette and Andrzej Szyszka

Telephone number

+33(1) 4212 1459 / +48(22) 317 4817

Name of offeree/offeror with which connected

ENERGY CAPITAL PARTNERS, LLC AND KOHLBERG KRAVIS ROBERTS & CO. L. P. (TOGETHER THE "CONSORTIUM")

Nature of connection (Note 9)

Advisor to Offeree

 

SUPPLEMENTAL FORM 38.5(b)

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DETAILS OF OPEN POSITIONS

 

OPEN POSITIONS (Note 1)

 

Product name,e.g. call option

Written or purchased

Number of relevant securities to which the option or derivative relates

Exercise price (Note 2)

Type, e.g. American, European etc.

Expiry date

Swap

Sold

189

0.0000

N/A

30/06/2026

 

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rules 8 and 38.5 of the Rules. If in doubt, consult the Panel.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ITPGZGZKGKFGVZM
Date   Source Headline
24th Nov 20255:26 pmRNSHolding in Company TR-1
21st Nov 20255:36 pmRNSHolding in Company TR-1
19th Nov 202510:16 amRNSHolding in Company TR-1
18th Nov 20256:05 pmRNSHolding in Company TR-1
17th Nov 20257:00 amRNSProposed return of up to £600m by tender offer
13th Nov 20255:55 pmRNSDirector/PDMR Shareholding
11th Nov 20257:00 amRNSResults for the six months ended 30 September 2025
3rd Nov 20257:00 amRNSCompletion of sale of Info Tech business
21st Oct 202512:30 pmRNSLiquid Gas Acquisitions
17th Oct 20259:50 amRNSHolding in Company TR-1
17th Oct 20257:00 amRNSDirector Declaration
15th Oct 20253:38 pmRNSHolding in Company TR-1
13th Oct 202512:45 pmRNSHolding in Company TR-1
7th Oct 20252:00 pmRNSHolding in Company TR-1
3rd Oct 20254:30 pmRNSHolding in Company TR-1
1st Oct 202512:43 pmRNSHolding in Company TR-1
25th Sep 20254:02 pmRNSHolding in Company TR-1
22nd Sep 20256:09 pmRNSHolding in Company TR-1
22nd Sep 202511:20 amRNSHolding in Company TR-1
12th Sep 20257:00 amRNSTransaction in Own Shares
11th Sep 20257:00 amRNSTransaction in Own Shares
10th Sep 20257:00 amRNSTransaction in Own Shares
10th Sep 20257:00 amRNSDCC Healthcare sale completes and capital return
9th Sep 20257:00 amRNSTransaction in Own Shares
8th Sep 20257:00 amRNSTransaction in Own Shares
5th Sep 20257:00 amRNSTransaction in Own Shares
4th Sep 20257:00 amRNSTransaction in Own Shares
3rd Sep 20257:00 amRNSTransaction in Own Shares
2nd Sep 20257:00 amRNSTransaction in Own Shares
1st Sep 202510:56 amRNSTotal Voting Rights
1st Sep 20257:00 amRNSTransaction in Own Shares
29th Aug 20257:00 amRNSTransaction in Own Shares
28th Aug 20257:00 amRNSTransaction in Own Shares
27th Aug 20257:00 amRNSTransaction in Own Shares
26th Aug 20257:00 amRNSTransaction in Own Shares
22nd Aug 20257:00 amRNSTransaction in Own Shares
21st Aug 20257:00 amRNSTransaction in Own Shares
20th Aug 20256:11 pmRNSHigh Court Approval of Reduction of Capital
20th Aug 20257:00 amRNSTransaction in Own Shares
19th Aug 20257:00 amRNSTransaction in Own Shares
18th Aug 20257:00 amRNSTransaction in Own Shares
15th Aug 20257:00 amRNSTransaction in Own Shares
14th Aug 20257:00 amRNSTransaction in Own Shares
13th Aug 20257:00 amRNSTransaction in Own Shares
12th Aug 20257:00 amRNSTransaction in Own Shares
11th Aug 20257:00 amRNSTransaction in Own Shares
8th Aug 20257:00 amRNSTransaction in Own Shares
7th Aug 20257:00 amRNSTransaction in Own Shares
6th Aug 20257:00 amRNSTransaction in Own Shares
5th Aug 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.